ストックスクリーナーアプリを入手
0.44
12.09%
-0.0605
アフターアワーズ：
.45
0.01
+2.27%
前日終値:
$0.5005
開ける：
$0.4296
24時間の取引高:
3.76M
Relative Volume:
1.39
時価総額：
$3.39M
収益：
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.00452
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-28.10%
1か月 パフォーマンス:
-70.47%
6か月 パフォーマンス:
-95.56%
1年 パフォーマンス:
-98.80%
1日の値動き範囲:
$0.4228
$0.4682
1週間の範囲:
$0.4228
$0.6137
52週間の値動き範囲:
$0.4228
$44.03
Aptevo Therapeutics Inc Stock (APVO) Company Profile
APVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
0.44 | 3.39M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-11-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-10-05 | 再開されました | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc (APVO) 最新ニュース
Aptevo Therapeutics announces common stock offering - Investing.com Australia
APVO’s latest rating updates from top analysts. - knoxdaily.com
Aptevo Therapeutics announces common stock offering By Investing.com - Investing.com India
Closing Bell Recap: Aptevo Therapeutics Inc (APVO) Ends at 0.61, Reflecting a -9.31 Downturn - DWinneX
Aptevo Therapeutics announces at-the-market offering - Investing.com Australia
APVO stock plunges to 52-week low, touches $0.59 - Investing.com
APVO stock plunges to 52-week low, touches $0.59 By Investing.com - Investing.com UK
Aptevo Therapeutics announces at-the-market offering By Investing.com - Investing.com India
SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow
Press Release Distribution & PR Platform - ACCESS Newswire
Applied Materials Q2 Earnings: Tech Giant's Financial Results Coming May 15 - Stock Titan
A look into Aptevo Therapeutics Inc (APVO)’s deeper side - Sete News
Aptevo Therapeutics Inc’s latest rating changes from various analysts - knoxdaily.com
Evogene (EVGN) Sees Dramatic Surge in Investor Interest Amid Strategic Moves | APVO Stock News - GuruFocus
Market Momentum: Aptevo Therapeutics Inc (APVO) Registers a 9.08 Increase, Closing at 0.69 - DWinneX
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus
Aptevo Therapeutics Raises Fresh Capital: $2M Direct Offering to Advance Cancer Drug Pipeline - Stock Titan
Aptevo Therapeutics Inc (APVO) Shares Are Down -85.25% YTD - Marketing Sentinel
Aptevo Therapeutics announces $2 million stock offering By Investing.com - Investing.com South Africa
Aptevo Therapeutics $2.0 Million Registered Direct Offering Pric - GuruFocus
Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus
Aptevo Therapeutics announces $2 million stock offering - Investing.com
Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan
Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com
How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com
Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus
Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Now Is A Good Time To Buy Aptevo Therapeutics Inc (NASDAQ: APVO) - Marketing Sentinel
APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa
APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia
Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Aptevo Secures Fresh $2.1M Capital: What This Means for Clinical Pipeline - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aptevo (APVO) Sees Significant Market Rally After Equity Offering - Stocks Telegraph
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise - MarketScreener
Aptevo Therapeutics (APVO) Announces $2.1 Million Securities Off - GuruFocus
Aptevo Therapeutics Inc (APVO) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
3.66%
大文字化:
|
ボリューム (24 時間):